Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study

Mycoses

Volumn 56, Issue 6, 2013, Pages 638-645

  Lewis, Russell E ^a,b   Cahyame Zuniga, Lizebeth ^a   Leventakos, Konstantinos ^a   Chamilos, Georgios ^a   Ben Ami, Ronen ^a   Tamboli, Pheroze ^a   Tarrand, Jeffrey ^a   Bodey, Gerald P ^a   Luna, Mario ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aspergillosis; Candidemia; Epidemiology

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; AUTOPSY; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDA TROPICALIS; CANDIDIASIS; CORTICOSTEROID THERAPY; CRYPTOCOCCUS NEOFORMANS; EPIDEMIOLOGICAL MONITORING; FUNGUS CULTURE; FUSARIOSIS; GASTROINTESTINAL TRACT; HEART; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE CANDIDIASIS; KIDNEY; MOULD; MUCORALES; MUCORMYCOSIS; NEUTROPENIA; NONHUMAN; OBSERVATIONAL STUDY; PHAEOHYPHOMYCOSIS; PNEUMOCYSTIS JIROVECI; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPLEEN; SYSTEMIC MYCOSIS;

ASPERGILLUS; MUCORALES;

ASPERGILLOSIS; CANDIDEMIA; EPIDEMIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGI; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOSES; PREVALENCE; YOUNG ADULT;

EID: 84886306657     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12081     Document Type: Article

References (34)

1. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36: 1-53.
2. Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695-703.
3. Neofytos D, Horn D, Anaissie E et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48: 265-73.
4. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47: 1041-50.
5. Park BJ, Pappas PG, Wannemuehler KA et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17: 1855-64.
6. Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091-100.
7. Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis 2010; 50: 405-15.
8. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients - a meta-analysis of randomized-controlled clinical trials. Cancer 2002; 94: 3230-46.
9. Chamilos G, Luna M, Lewis RE et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-9.
10. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009; 48: 1033-41.
11. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-63.
12. Thors VS, Bierings MB, Melchers WJ, Verweij PE, Wolfs TF. Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy. Pediatr Infect Dis J 2011; 30: 268-70.
13. Snelders E, van der Lee HA, Kuijpers J et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 11: e219.
14. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123-9.
15. Dodds-Ashley ES, Lewis RE, Lewis JS, Martin C, Andes D. Pharmacology of systemic antifungal agents. Clin Infect Dis 2006; 43(Suppl. 1): S28-39.
16. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
17. Pagano L, Caira M, Candoni A et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 2010; 95: 644-50.
18. Lehrnbecher T, Frank C, Engels K, Kriener S, Groll AH, Schwabe D. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infection 2010; 61: 259-65.
19. Shojania KG, Burton EC. The vanishing nonforensic autopsy. N Engl J Med 2008; 358: 873-5.
20. Subira M, Martino R, Rovira M, Vazquez L, Serrano D, De la Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82: 80-2.
21. Tarrand JJ, Han XY, Kontoyiannis DP, May GS. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol 2005; 43: 382-6.
22. Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol 2007; 127: 208-12.
23. Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA 2003; 289: 2849-56.
24. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-26.
25. Odenike O, Thirman MJ, Artz AS, Godley LA, Larson RA, Stock W. Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet? Semin Oncol 2011; 38: 196-214.
26. Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494-503.
27. Lewis RE, Kontoyiannis DP. Invasive aspergillosis in glucocorticoid-treated patients. Med Mycol 2009; 47: S271-81.
28. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect 2009; 15(Suppl. 5): 93-7.
29. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
30. Sipsas NV, Lewis RE, Tarrand J et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 2009; 115: 4745-52.
31. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112: 2493-9.
32. Kontoyiannis DP, Reddy BT, Torres HA et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 2002; 34: 400-3.
33. Kofteridis DP, Lewis RE, Kontoyiannis DP. Caspofungin-non-susceptible Candida isolates in cancer patients. J Antimicrob Chemother 2010; 65: 293-5.
34. Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother 2008; 52: 4181-3.